首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1510435

藥用輔料市場規模- 按產品（有機、無機）、功能（黏合劑、懸浮劑和黏度劑、填充劑和稀釋劑、防腐劑）配方（口服{片劑、膠囊}、液體、腸胃外、外用）和預測，2024 - 2032

Pharmaceutical Excipients Market Size - By Product (Organic, Inorganic), Functionality (Binder, Suspension & Viscosity Agents, Filler & Diluent, Preservatives) Formulation (Oral {Tablet, Capsule}, Liquid, Parenteral, Topical) & Forecast, 2024 - 2032

出版日期: 2024年04月01日 | 出版商:

Global Market Insights Inc. | 英文 285 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024 年至2032 年間，藥用輔料市場規模的複合年成長率將超過8%。增強藥物配方。這些賦形劑可提高活性藥物成分的穩定性、溶解度和生物利用度，最終提高藥物製劑的功效。新藥物輸送技術的出現也為原料製造商提供了滿足不斷變化的生產需求的機會。

合約開發和製造組織活動的增加將刺激市場擴張。外包使公司能夠專注於研發，同時利用 CDMO/CMO 的專業知識和基礎設施進行藥物生產。藥品生產的法律標準要求來自可靠供應商的高品質補充劑，進一步增加了產品需求。例如，2023 年 10 月，科萊恩推出了三種新的 VitiPure(R) 賦形劑，以增強 API 配方，特別是針對 mRNA 疫苗和生物製劑等精緻產品。

藥用輔料產業分為產品、功能、配方和地區。

根據產品，到 2032 年，無機化學品領域的市場價值預計將成長 7.9%。它們具有高水平的純度、穩定性以及與活性成分的相容性。界面活性劑提供獨特的功能特性，例如控制釋放和結合。無機添加劑，如鹽、礦物質和金屬，也可用於定製配方以滿足特定要求。

由於注射藥物的配方和輸送的獨特要求，預計 2024 年至 2032 年，注射劑領域的藥用輔料市場複合年成長率將達到 7.9%。注射劑和靜脈注射藥物等腸外產品需要添加劑以確保穩定性以及與活性成分的相容性。賦形劑對於提高溶解度、控制輸送以及滿足清潔度和純度監管標準至關重要。由於慢性病盛行率不斷上升以及對標靶治療的強烈需求，腸外給藥的需求持續上升，對關鍵基礎設施的優質開發商的需求不斷增加，有利於該細分市場的成長。

亞太地區藥用輔料產業將實現令人矚目的成長，到2032 年複合年成長率為8.4%。推動對輔料的需求。對醫療保健基礎設施的投資和慢性病的增加也增加了亞太地區對輔料的需求。

產業生態系統分析
產業影響力
- 成長動力
  - 對藥品和學名藥的需求不斷成長
  - 輔料的開發進展
  - 專利到期導致對輔料的需求增加
  - 加強製藥公司的夥伴關係和合作
- 產業陷阱與挑戰
  - 輔料的不良反應
  - 缺乏適當的核准流程
成長潛力分析
定價分析
技術分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
公司市佔率分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
有機化學品
- 油脂化學品
  - 脂肪醇
  - 礦物硬脂酸鹽
  - 甘油
  - 其他油脂化學品
- 碳水化合物
  - 糖
    - 實際糖分
    - 糖醇
    - 人工甜味劑
  - 纖維素
    - 微晶纖維素
    - 纖維素醚
    - CMC & 交聯羧甲基纖維素鈉
    - 纖維素酯
  - 澱粉
    - 修飾澱粉
    - 乾澱粉
    - 修飾澱粉
- 石化產品
  - 乙二醇
  - 礦物碳氫化合物
  - 丙烯酸聚合物
  - 其他石化產品
- 蛋白質
- 其他有機化學品
無機化學品
- 磷酸鈣
- 金屬氧化物
- 岩鹽
- 碳酸鈣
- 硫酸鈣
- 其他無機化學品
其他產品

第 6 章：市場估計與預測：按功能分類，2021 - 2032 年

主要趨勢
活頁夾
懸浮劑和增粘劑
助流劑
防腐劑
填充劑和稀釋劑
潤滑劑
乳化劑
崩解劑
其他功能

第 7 章：市場估計與預測：按配方分類，2021 - 2032 年

主要趨勢
口服
- 藥片
- 膠囊
  - 硬明膠
  - 軟明膠
- 其他口服製劑
液體
注射用
專題
其他配方

第 8 章：市場估計與預測：按地區，2021 - 2032

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 中東和非洲其他地區

第 9 章：公司簡介

Air Liquide S.A.
Archer Daniels Midland Company
Ashland
Associated British Foods PLC
BASF SE
Croda International PLC
Evonik Industries AG
Innophos
Kerry Group plc
Merck KGaA

簡介目錄

Product Code: 8780

Pharmaceutical excipients market size is estimated to register over 8% CAGR between 2024 and 2032. With the rising demand for dietary supplements alongside the increasing need for pharmaceuticals, excipients have grown essential as they help in enhancing drug formulations. These excipients improve stability, solubility, and bioavailability of active pharmaceutical ingredients, ultimately boosting the efficacy of drug formulations. The emergence of new drug delivery technologies is also presenting an opportunity for ingredient manufacturers to cater to evolving production needs.

Increased activities in contract development and manufacturing organizations will spur the market expansion. Outsourcing allows companies to focus on R&D while utilizing the expertise and infrastructure of CDMOs/CMOs for drug production. Legal standards for drug manufacturing require high-quality supplements from reliable suppliers, further boosting the product demand. For instance, in October 2023, Clariant launched three new VitiPure(R) excipients to enhance API formulations, especially for delicate products like mRNA vaccines and biologics.

The pharmaceutical excipients industry is segmented into product, functionality, formulation and region.

Based on product, the market value from the inorganic chemicals segment is projected to witness 7.9% growth rate through 2032. Inorganic chemicals are essential for pharmaceutical formulations to maintain quality and potency. They offer high levels of purity, stability, and compatibility with active ingredients. Surfactants provide unique functional properties like controlled release and binding. Inorganic additives, such as salts, minerals, and metals can also be used to customize formulations to meet specific requirements.

Pharmaceutical excipients market from the parenteral segment is anticipated to observe 7.9% CAGR from 2024 to 2032, owing to unique requirements for formulation and delivery of injectable pharmaceuticals. Parenteral products like injections and IV medications need additives for stability and compatibility with the active ingredient. Excipients are crucial in improving solubility, controlling delivery, and meeting regulatory standards for cleanliness and purity. As the demand for parenteral drug delivery continues to rise due to the increasing prevalence of chronic diseases and strong need for targeted therapies, the demand for quality developers for key infrastructure is increasing, favoring the segment growth.

Asia Pacific pharmaceutical excipients industry will record impressive growth, depicting an 8.4% CAGR through 2032. The expansion of the pharmaceutical industry in developing countries like China, India, and Southeast Asian countries is driving the demand for excipients due to increased healthcare infrastructure and spending, as well as the rising need for affordable medicines. Investments in healthcare infrastructure and increasing chronic diseases are also contributing to the need for excipients in APAC.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing demand for pharmaceutical and generic drugs
  - 3.2.1.2 Advancement in development of excipients
  - 3.2.1.3 Increased demand for excipients due to expiration of patents
  - 3.2.1.4 Increasing partnership and collaboration of pharmaceutical companies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Adverse effects of excipients
  - 3.2.2.2 Lack of proper approval process
3.3 Growth potential analysis
3.4 Pricing analysis
3.5 Technology analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Organic chemicals
- 5.2.1 Oleochemicals
  - 5.2.1.1 Fatty alcohols
  - 5.2.1.2 Mineral stearates
  - 5.2.1.3 Glycerin
  - 5.2.1.4 Other oleochemicals
- 5.2.2 Carbohydrates
  - 5.2.2.1 Sugar
    - 5.2.2.1.1 Actual sugar
    - 5.2.2.1.2 Sugar alcohols
    - 5.2.2.1.3 Artificial sweeteners
  - 5.2.2.2 Cellulose
    - 5.2.2.2.1 Microcrystalline cellulose
    - 5.2.2.2.2 Cellulose ethers
    - 5.2.2.2.3 CMC & croscarmellose sodium
    - 5.2.2.2.4 Cellulose esters
  - 5.2.2.3 Starch
    - 5.2.2.3.1 Modified starch
    - 5.2.2.3.2 Dried starch
    - 5.2.2.3.3 Converted starch
- 5.2.3 Petrochemicals
  - 5.2.3.1 Glycols
  - 5.2.3.2 Minerals hydrocarbons
  - 5.2.3.3 Acrylic polymers
  - 5.2.3.4 Other petrochemicals
- 5.2.4 Proteins
- 5.2.5 Other organic chemicals
5.3 Inorganic chemicals
- 5.3.1 Calcium phosphate
- 5.3.2 Metal oxides
- 5.3.3 Halites
- 5.3.4 Calcium carbonate
- 5.3.5 Calcium sulfate
- 5.3.6 Other inorganic chemicals
5.4 Other products

Chapter 6 Market Estimates and Forecast, By Functionality, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Binder
6.3 Suspension and viscosity agents
6.4 Glidants
6.5 Preservatives
6.6 Filler & diluent
6.7 Lubricant
6.8 Emulsifier
6.9 Disintegrant
6.10 Other functionalities

Chapter 7 Market Estimates and Forecast, By Formulation, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Oral
- 7.2.1 Tablet
- 7.2.2 Capsule
  - 7.2.2.1 Hard gelatin
  - 7.2.2.2 Soft gelatin
- 7.2.3 Other oral formulations
7.3 Liquid
7.4 Parenteral
7.5 Topical
7.6 Other formulations

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa